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demic nephropathy (BEN).
Background. Balkan endemic nephropathy (BEN) is of
great clinical importance in restricted areas of Bulgaria, Serbia,
Croatia, Bosnia, Herzegovina, and Romania, since the etiology
of BEN is still unknown.
Methods. In urine samples from 48 patients (41 females and
7 males, aged 65.6 6.87 years) with BEN living in an endemic
area of Vratza district, Bulgaria, neopterin concentrations were
measured by high-pressure liquid chromatography (HPLC)
and compared with other clinical and laboratory investigations,
including creatinine, hemoglobin, and erythrocyte sedimenta-
tion rates (ESRs).
Results. Urinary neopterin concentrations were 263  128
(mean  SD; range, 78 to 786 mol/mol creatinine), 24 (50%)
of BEN patients presented with increased concentrations as
compared to the established normal ranges. Average ESRs
were increased (1 hour, 29.0 14.7 mm/hour) and hemoglobin
was decreased (109.3  16.4 g/L). Hemoglobin correlated in-
versely with ESRs (rs  0.787 and –0.780) and creatinine
concentrations (r  0.690, all P  0.001), but not with neo-
pterin concentrations. Neopterin concentrations also did not
correlate with serum creatinine levels. There existed an age
relationship of ESR, creatinine, and hemoglobin, but not of
neopterin. Neopterin concentrations were slightly lower in five
females with low titers of antibodies against local B1 hantavirus
strain (P  0.05).
Conclusion. The findings can support an immune-mediated
inflammatory process in the pathogenesis of BEN only in a
subgroup of patients.
Balkan endemic nephropathy (BEN) is of great clini-
cal importance in restricted areas of the Balkany. In
these countries, BEN, a chronic tubulointerstitial kidney
disease, is regarded as a national problem of majority
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[1]. The onset is in childhood with a latent period of
several decades and it is clinically expressed usually only
at an advanced stage of renal failure. A female predomi-
nance was established. BEN is characterized by anemia,
absence of hypertension, gradually destroyed renal func-
tion, a low-degree proteinuria and poor urinary sedi-
ment. The pathologic process progresses to intense fi-
brosis and tubular atrophy, and at the end stage of the
disease, renal failure develops. About 30% to 48% of
BEN patients develop transitional-cell tumors of the up-
per urothelium. Tumors are usually malignant, multiple,
and two thirds have bilateral localization in the renal
pelvis, one third in the urethra and in the bladder [2].
The etiology of BEN is unknown. Different hypothe-
ses try to explain the striking endemic distribution of the
disease with an etiologic role of genetic factors, exoge-
nous factors (i.e., heavy metals, fungal toxins as ochra-
toxin A, inorganic compounds), or infectious agents
[3–11].
Concepts of the possible role of hereditary factors
and infectious agents as well as predisposition to tumor
development suggest an involvement of immune mecha-
nisms in the pathogenesis of the disease.
In this study, urine samples of BEN patients were
collected and tested for the concentration of neopterin.
Neopterin is produced in large amounts by monocyte-
derived macrophages upon activation with Th1-type cy-
tokine interferon-, and increased neopterin concentra-
tions are characteristic for cellular immune activation
[12, 13].
METHODS
Five endemic villages from Vratza district (Gorno
Peshtene, Tishevitza, Vesletz, Beli Izvor, and Pudria),
all in Bulgaria, were screened for BEN. First-morning
urine samples from 48 patients (41 women and seven
men; age, 65.5  6.9 years; range, 52 to 79 years) with
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BEN living in the endemic area were collected. Speci-
mens were kept at –20C until measured.
Clinical investigations comprised blood tests [hemo-
globin concentrations, red blood cells, leukocytes, and
erythrocyte sedimentation rate (ESR), blood urea, creat-
inine, and uric acid] and urine analyses (pH, protein,
glucose, bilirubin, urobilinogene, blood, nitrite, specific
urine weight, ketons, and leukocytes). None of the pa-
tients showed symptomatology of any acute viral infec-
tion.
Neopterin and creatinine concentrations in urine sam-
ples were determined by high-pressure liquid chromatog-
raphy (HPLC) [12]. Briefly 100 mL of urine was diluted
in 1 mL 15 mmol/L Soerensen potassium phosphate buf-
fer, pH 6.4 containing 5 mmol/L ethylenediaminetetra-
acetic acid (EDTA). Neopterin and creatinine were sep-
arated by reversed-phase HPLC and expressed as mol
neopterin per mol creatinine ratio to take into account
variations of urine dilution [12]. As stationary phase, a
LiChroCART 125-4 column (RP-18 endcapped, grain
size 5 m) (Merck, Darmstadt, Germany) was used, the
mobile phase was a 15 mmol/L potassium phosphate
buffer, pH 6.4 (Soerensen). Neopterin was quantified by
its natural fluorescence (excitation at 353 nm wavelength;
emission at 438 nm wavelength) and creatinine was si-
multaneously quantified by ultraviolet absorption at 235
nm wavelength in one single run [12]. HPLC measure-
ments were performed in subsequent runs within 1 day.
Intra-assay variation of the HPLC method is 6% [12].
Preliminary virus analyses could be performed only
in a subgroup of 34 individuals. By indirect immunofluo-
rescence, antibodies against nephrotopic viruses with en-
demic areas of circulation [e.g., hantaviruses (hantavirus
strains, standard Hantaan and F3955, local B1)] and West
Nile flavivirus virus were analyzed.
Because not all laboratory results showed normal dis-
tribution, for comparisons of groups nonparametric Mann
Whitney U-test was employed. Associations between
neopterin concentrations, age, and other laboratory re-
sults of patients were calculated by Spearman rank corre-
lation analysis.
RESULTS
Demographic data and neopterin concentrations in
the individual urine samples are shown in Table 1. In-
creased neopterin concentrations were observed in 50%
of the BEN patients, as compared to the 95th percentile
of healthy controls [12] (Table 1). Mean neopterin con-
centration was 263.1 mol/mol creatinine (see Table 2),
which exceeds the upper limits of normal for men and
women of all age groups. Elevated ESRs, as well as
decreased hemoglobin concentrations, were also evident
in the patients (Table 2).
There was no difference of neopterin concentrations
between men and women, and there existed no correla-
tions between neopterin and age and also not to other
available laboratory parameters (Table 3). Creatinine
concentrations correlated positively with ESRs and in-
versely with hemoglobin levels. In addition, lower hemo-
globin levels were associated with higher ESRs (Table
2). When splitting the patients into two groups at the
median creatinine concentration (132 mol/L), the
group with higher creatinine concentrations presented
with lower hemoglobin (mean  SD, 101.5  15.7 g/L;
P  0.001) and higher ESRs (ESR 1 hour, 33.8  16.0
mm/hour; P  0.01) as compared with the group with
lower creatinine (hemoglobin, 118.9  10.6 g/L; ESR 1
hour, 22.9  10.4 mm/hour). No such differences were
found for age and urinary neopterin concentrations. Of
the two patients on hemodialysis, one presented with
the highest (786 mol neopterin/mol creatinine), the
other with the lowest neopterin concentration (78
mol neopterin/mol creatinine) of all patients. Age cor-
related only weakly and positively with creatinine and
ESRs and negatively with hemoglobin, and when pa-
tients were split in two groups at the median of their
age (65 years), there was no difference between any
of the parameters (all P 	 0.05).
There was no difference between any of the measured
parameters in cases with and without BEN family his-
tory. BEN patients with diagnosed malignancy were
older (73.0 3.67 years; N  5) than those without such
diagnosis (64.6  6.63 years, P  0.01), but again, none
of the laboratory parameters differed between the two
groups of BEN patients. All the results of statistical
analyses did not change when two patients on hemodialy-
sis were excluded.
Preliminary data in a subgroup of 34 patients revealed
comparatively low levels of antibodies against hantavirus
strains (standard Hantaan and F3955, local B1) in nine
patients (27%) (Table 4). Besides, in two cases (two out
of 34) (6%) anti-West Nile virus antibodies have been
recorded (Table 4). There was no association between
the serologic findings and any of the laboratory measure-
ments with the exception of neopterin: neopterin concen-
trations were lower in the 5 females seropositive for local
hantavirus strain B1 (168.2 
 66.1 mol neopterin/mol
creatinine) compared to residual seronegative BEN pa-
tients (279.3
 144.3mol neopterin/mol creatinine; U
1.98, P  0.05).
DISCUSSION
The monitoring of neopterin concentrations in body
fluids is a sensitive way to detect Th1-type immune re-
sponse [12, 13] initiated by various causes. Measure-
ments of neopterin concentrations in urine, serum or
cerebrospinal fluid are employed as a laboratory diag-
nostic tool (e.g., to earlier detect immunologic complica-
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Table 1. Demographic characteristics and neopterin concentrations in urine samples of Balkan endemic nephropathy (BEN) patients
Age Creatinine Neopterin lmol/mol
Patient Gender years Diagnosis lmol/L creatinine
8 F 71 CRI, family history 187 190
9 F 65 CRI (hemodialysis) 1243 78
16 F 75 Primary RT, nephrectomy (right) 175 252
44 F 62 66 259
69 F 76 Family history 150 388
70 F 74 Family history 142 314
108 F 57 Family history 126 220
139 F 64 Family history 118 162
162 M 62 CRI 240 212
187 F 69 Family history 134 255
192 F 67 Obstructive RT, hematuria 119 302
207 F 61 Family history 106 348
212 F 76 Primary bladder tumor, cystostoma 147 186
236 F 57 Family history 140 171
253 F 61 Family history (sister of 306) 141 379
306 F 65 Family history (sister of 253) 132 350
419 F 72 Primary RT, nephrectomy (left) 87 426
464 M 52 95 163
546 F 61 Family history (sister of 20) 136 200
563 F 67 Family history (sister of 19) 126 166
620 F 55 136 252
638 M 75 RT (right) 612 205
640 F 66 136 250
660 F 60 116 143
675 F 63 135 205
686 F 78 Family history 124 547
695 F 58 Family history 100 174
720 F 62 89 203
824 F 58 Family history (two brothers dead) 106 176
826 M 69 128 242
833 F 59 86 396
848 F 67 Family history (two brothers dead) 132 469
929 F 69 Family history (sister of 930) 130 262
930 M 65 Family history (brother of 929) 108 412
935 F 77 79 148
959 F 59 Family history 136 490
968 F 62 Family history 128 248
969 F 61 Family history (parents dead) 156 292
970 F 75 Anemia 420 214
1047 F 69 Family history (husband dead) 138 204
1059 F 69 126 164
1069 F 79 182 235
1087 F 69 144 144
1130 F 58 120 231
1164 M 68 116 215
1168 F 57 Family history (parents dead) 156 130
1254 M 66 Family history, CRI Hemodialysis 786
1325 F 56 96 171
Abbreviations are: CRI, chronic renal insufficiency; RT, renal tumor. Age-related upper limits of normal, 95th percentiles in healthy individuals [12]: females 46
to 55 years, 229; 56 to 65 years, 249; 	65 years, 251; males 46 to 55 years, 197; 56 to 65 years, 218; 	65 years, 229 (all concentrations in mol neopterin/mol creatinine).
Table 2. Neopterin concentrations and erythrocyte
sedimentation rates (ESR) in 48 patients with
Balkan endemic nephropathy (BEN)
Mean SD Range
Urinary neopterin lmol/mol creatinine 263 128 78–786
Hemoglobin g/L 109 16.4 55–140
ESR
1 hour 29.0 14.7 7–68
2 hours 52.7 25.2 15–110
Creatinine lmol/L 169 182 66–1243
tions in transplant recipients or to predict prognosis in
HIV infection and malignancy) [12]. Neopterin concen-
trations are also increased with high frequency during
acute virus infections [12, 14]. Neopterin concentrations
were found to be increased during episodes of viral infec-
tion, including acute hepatitis A and B [15], Epstein-
Barr virus (mononucleosis), cytomegalovirus [14, 16],
and measles [17]. In cytomegalovirus infections [16], in-
creased neopterin concentrations are observed in the
majority of patients before antibody seroconversion be-
comes detectable. Usually neopterin concentrations nor-
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Table 3. Associations between age and laboratory characteristics
of patients with Balkan endemic nephropathy (BEN)
ESR ESR
Hemoglobin (1 hour) (2 hours) Creatinine Age
Neopterin 0.032 0.226 0.221 0.055 0.174
NS NS NS NS NS
Hemoglobin 0.787 0.780 0.690 0.261
0.001 0.001 0.001 0.05
ESR (1 hour) 0.972 0.487 0.313
0.001 0.001 0.05




r and P values in brackets are shown; NS is not significant.
malize after seroconversion and when clinical symptom-
atology has ceased. However, elevated serum and urine
neopterin concentrations levels cannot only be detected
in acute and late stage of HIV infection, they are also
found in more than 75% of patients with asymptomatic
HIV-1 infection [18, 19].
Renal impairment may increase blood neopterin con-
centrations [18]. Therefore, we decided to determine
urinary neopterin concentrations expressed as the neo-
pterin per creatinine ratio. Data of this study show that
there was no relationship between serum creatinine and
urine neopterin concentrations when expressed as mol
neopterin/mol creatinine. The lacking association be-
tween creatinine and urinary neopterin concentrations
is further strengthened by the observation that patients
on hemodialysis (N 2) presented, on the one hand, with
the lowest and, on the other, with the highest neopterin
concentrations of the study population.
Because, among other reasons, viral infection is dis-
cussed as a possible cause for BEN [8–11], it was of
interest to examine neopterin concentrations in urine
samples from BEN patients. However, only 50% of BEN
patients presented with elevated neopterin concentra-
tions compared to healthy controls. There was no differ-
ence between BEN patients with and without family
history. Survival of BEN cases with family history was
found longer when compared with BEN cases without
family history [20]. Again, these subgroups in our study
did not differ regarding their neopterin concentrations.
Only a few patients tested weakly positive for antibodies
against hantavirus strains or anti-West Nile virus. Five
females seropositive for local hantavirus strain B1 had
lower neopterin concentrations than seronegative BEN
patients. The number of patients tested was limited and
the titers measured were low, still the result would fit to
the earlier observation that higher neopterin concentra-
tions, indicating cellular (Th1-type) immune activa-
tion, are related to lower Th2-type markers such as IgE
or antibody titers [21, 22] in the sense of a cross-regula-
tory influence of Th1- versus Th2-type cytokines. Never-
Table 4. Antibodies against West Nile virus (WNV) and hantavirus
strains in serum samples of 34 patients with Balkan endemic
nephropathy (BEN) (indirect immunofluorescence test)
Antibodies (reciprocal titer values) against
Patient WNV Egypt Hantavirus Hantaan F3955 B1
8 — — — 10
9 — — — 10
16 — — — —
44 — — — 10
69 20 — — —
70 — — — —
546 — — 10 —
563 — — — —
620 — — — —
638 — — — —
640 — — 10 —
660 — 40 80 80
675 — — — —
686 — — — —
695 — — — —
720 — — — —
824 — — — —
826 — — — —
833 — — — —
848 — — — —
929 — — — —
930 — — — —
935 — — — —
959 — — — —
968 — — 10 —
969 — — — —
970 — — — —
1047 — — — —
1059 — — — —
1087 — — — —
1130 — 20 20 —
1164 — 80 — —
1254 — — — —
1325 20 — — 20
theless, our observations would fit the notion that at
least half of the patients examined in this study do not
comprise patients suffering from acute virus infections.
Earlier studies show that malignant tumor diseases
are frequently associated with increased neopterin con-
centrations [23]. Thereby, higher neopterin concentra-
tions are associated with shortened survival. Half of the
BEN patients presented with increased neopterin con-
centrations, which is similar to the frequencies with ele-
vated neopterin observed earlier in patients with solid
cancer such as gynecologic neoplasias or cancer of the
prostate. However, only a minority of our BEN patients
presented with tumors, and their neopterin concentra-
tions did not differ from patients without such diagnosis.
A possible predictive value of neopterin concentrations
still has to be demonstrated.
In several malignant and infectious diseases, an associ-
ation between higher neopterin concentrations and
lower hemoglobin concentrations was observed [24].
This was not found in our study population. In addition,
in chronic or protracted infections very often an associa-
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tion exists between neopterin concentrations and ESR
[24–26], again this was not true in our individuals. With
this respect, patients with BEN differ considerably from
observations made in patients with infections or malig-
nant diseases.
The lack of a strong increase of neopterin concentra-
tions may reflect the very slow progression of BEN,
the pauci-cellular infiltrates, marked interstitial fibrosis
without prominent inflammation. The absence of ele-
vated neopterin concentrations in patients with malig-
nant tumors might be due to the characteristically super-
ficial, epithelial type of tumors seen in BEN patients.
Overall, the absence of increased neopterin in half of
the patients might support the hypothesis of a toxic ne-
phropathy with a genetic predisposition and may argue
against an ongoing viral infection.
CONCLUSION
Approximately 50% of BEN patients present with in-
creased urinary neopterin levels. The patients with ele-
vated neopterin levels did not have a higher degree of
renal insufficiency, and there were no differences in other
variables studied between the patients with increased
neopterin and those with normal values. The background
of this elevation, whether it is infectious or of other
origin, remains unresolved. Also, an association between
higher neopterin and ESR or lower hemoglobin con-
centrations, which is commonly observed in infections
and malignant processes, is obviously missing in patients
with BEN.
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